Hanmi shares obesity drug approval has led to a sharp reversal. What does this mean for investors?
Life-saving cancer drugs are costing patients exorbitant prices. Discover why the government is being criticized for these inflated costs.
FDA approval for Atebrioz brings hope to FOP patients aged 12 and older.
Developmental care platform is expanding. Discover the proven benefits and impacts of this growth in the U.S. market.
Capricor DMD therapy faces challenges as the company launches a legal fight ahead of the FDA review.
